The Controversy of Weight Loss Drugs and the Commodification of Health

This chapter discusses the emerging weight loss drug semaglutide, focusing on its appetite-suppressing abilities and the skepticism surrounding its long-term sustainability and health risks. It critiques the commodification of health solutions and connects this trend to the societal challenge of accepting natural human traits.